Company Performance: Net profits, revenue growth, and strategic developments like new product launches directly impact investor confidence and thus stock prices.

Industry Trends: Overall health and growth prospects of the pharmaceutical sector, including regulatory changes and technological advancements, affect investor sentiment.

Market Sentiment: General investor optimism or pessimism driven by economic data, geopolitical events, or broader market trends influences trading activity and stock valuation.

Regulatory Environment: Government policies, drug approvals, pricing regulations, and healthcare reforms can significantly alter the company's profitability and growth potential.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and GDP growth affect consumer spending and business investment, impacting the company's financials.

Competitive Landscape: The actions of competitors, including pricing strategies, new product launches, and market share gains or losses, influence investor perceptions of the company.

Global Health Crises: Outbreaks of infectious diseases or pandemics can create heightened demand for healthcare products, potentially impacting the company's revenue and stock value.

Investor Perception: News articles, analyst ratings, and public opinion about the company impact demand for shares, influencing the price.